Virtual Reality for Anxiety and Pain Management in Transvaginal Ultrasound for Endometriosis
NCT ID: NCT07328061
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
155 participants
INTERVENTIONAL
2023-12-10
2024-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants, women undergoing TVUS for endometriosis will be randomly assigned to either VR distraction group (VR-TVUS) or a standard examination group (control).
Anxiety and pain levels will be assessed immediately before and after the TVUS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Virtual Reality System for Pain and Anxiety Management During Outpatient Hysteroscopy
NCT04625920
The Effect of Virtual Reality on Anxiety and Pain During Endometrial Biopsy
NCT06180317
Virtual Reality Effects on Pain During Hysteroscopy Hysteroscopy: A Randomized Control Trial
NCT04802460
The Effect of Virtual Reality on Women Undergoing Endometrial Biopsy
NCT06961097
Virtual Reality for Pain Management and Patient Satisfaction During Outpatient Hysteroscopy
NCT06463210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VR- TVUS Group
Participants undergo TVUS while using immersive virtual reality distraction
Virtual reality - based distraction
Participants use an immersive virtual reality headset during TVUS. The intervention consists of immersive three-dimensional (3D) VR distraction delivered a head-mounted display, allowing participants to engage with a computer-simulated virtual environment, with or without guided audio based mindfulness relaxation techniques. The intervention is designed to reduce pain and anxiety during US examination. Each session lasts approximately 10-15 minutes, and may include calming music or guided meditation audio
Contro Group - Standard TVUS
Participants undergo standard TVUS, without virtual reality or any additional distraction intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual reality - based distraction
Participants use an immersive virtual reality headset during TVUS. The intervention consists of immersive three-dimensional (3D) VR distraction delivered a head-mounted display, allowing participants to engage with a computer-simulated virtual environment, with or without guided audio based mindfulness relaxation techniques. The intervention is designed to reduce pain and anxiety during US examination. Each session lasts approximately 10-15 minutes, and may include calming music or guided meditation audio
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed or suspected diagnosis of endometriosis.
* Scheduled to undergo transvaginal ultrasound examination.
* Ability to understand the study procedures and independently complete study questionnaires.
* Provided written informed consent.
Exclusion Criteria
* History of migraines.
* Visual or hearing impairment.
* Diagnosed anxiety disorders.
* Claustrophobia.
* Current symptoms of dizziness or nausea.
* Active respiratory tract infection.
* Any contraindication to transvaginal ultrasound examination.
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michal Zajicek
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Endometriosis Center, Sheba Medical Center
Ramat Gan, Central District, Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0142-23-SMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.